Abstract C36H32N8O8V2, monoclinic, P\2\lc\ (no. 14), a = 16.879(2) A, b = 6.5076(7) A, c = 16.893(2) A, β = 111.259(1)°, V= 1729.3 A 3 , Ζ = 2, RgJF) = 0.041, wRmtfF 2 ) = 0.115, Γ = 293 Κ.
Source of material
The ligand 2-hydroxy-l-naphthaldehyde isonicotinyl hydrazone was prepared according to [1] . 0.13 g VO(acac)2 was dissolved in 10.0 ml CH3OH, and was added dropwise to an methanol solution of 0.15 g 2-hydroxy-l-naphthaldehyde isonicotinyl hydrazone under continuous stirring. The reaction lasted for 2 hours, and a mixture of 5.5 ml CH3OH and 5.5 ml ethylenediamine was added. After filtration, the brownish filtrate was layered with Et2Ü, allowed to stand at room temperature. Brown plate-like crystals suitable for X-ray diffraction were obtained after 3 days. Vanadium(IV) was oxidized to vanadium(V) by atmospheric oxygen.
Experimental details
The very small Ngt/Nparam ratio is caused by the low quality of the crystals.
Discussion
Vanadium plays an important role in biological systems and some of the vanadium complexes with organic ligands might be candidates for therapy of diabetes. Consequently, design and synthesis of the new complexes have been of great interest recently [2, 3] . In the title complex, the coordinating ligand atoms, a monoanionic ΟΝΟ donor, and the two oxo-oxygen atoms form a trigonal bipyramid around the metal center VI. The imine nitrogen atom Nl, the two oxygen atoms 03 and 04 as well as die metal center constitute the equatorial plane, and the axial positions 
